Shares of ) were down 5.7% at midday on Tuesday. Stock traded as low at $0.61, and was last traded at $0.62. Around 74,592 share were traded at midday, which is a 97% decrease from the daily average of 2,816,332. Stock had closed previously at $0.66.
Creative Medical Technology Price Performance
CELZ has been the subject of recent changes by several large investors. Citadel Advisors LLC purchased a new stake of about $113,000 in Creative Medical Technology during the third quarter. Aaron Wealth Advisors LLC purchased a new stake of about $38,000 in Creative Medical Technology during the 4th Quarter. Geode Capital Management LLC increased their holdings in Creative Medical Technology in the first quarter by 261.8%. Geode Capital Management LLC owns 124 224 shares worth $62,000, after purchasing an additional 89 886 shares during the last quarter. Vanguard Group Inc. purchased a new stake worth approximately $98,000 in Creative Medical Technology during the first quarter. State Street Corp also bought a stake in Creative Medical Technology during the first quarter, worth approximately $90,000. Hedge funds, other institutional investors and pension funds own 4.19%.
Creative Medical Technology
Creative Medical Technology Holdings, Inc. is a biotechnology company in the commercial stage that focuses on immunology, neurology, orthopedics, and urology using adult stem cells treatments and related regenerative technologies to treat multiple indications. CaverStem is one of its products. Others include FemCelz StemSpine and ImmCelz.
MarketBeat.com offers a FREE daily email newsletter